Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125607972 | 12560797 | 2 | F | 20140606 | 20160803 | 20160715 | 20160815 | EXP | US-BAYER-2016-106923 | BAYER | 50.00 | YR | A | F | Y | 0.00000 | 20160815 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125607972 | 12560797 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | |||
| 125607972 | 12560797 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | |||
| 125607972 | 12560797 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | |||
| 125607972 | 12560797 | 4 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | Y | 0 | 75 | MG | QD | ||||||
| 125607972 | 12560797 | 5 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 81 MG, QD | Y | 999999 | 81 | MG | QD | ||||||
| 125607972 | 12560797 | 6 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | UNK | Y | 999999 | |||||||||
| 125607972 | 12560797 | 7 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125607972 | 12560797 | 1 | Atrial fibrillation |
| 125607972 | 12560797 | 2 | Cerebrovascular accident prophylaxis |
| 125607972 | 12560797 | 3 | Anticoagulant therapy |
| 125607972 | 12560797 | 4 | Arrhythmia |
| 125607972 | 12560797 | 5 | Product used for unknown indication |
| 125607972 | 12560797 | 6 | Product used for unknown indication |
| 125607972 | 12560797 | 7 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125607972 | 12560797 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125607972 | 12560797 | Epistaxis | |
| 125607972 | 12560797 | Faeces discoloured | |
| 125607972 | 12560797 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125607972 | 12560797 | 1 | 20140611 | 201406 | 0 | |
| 125607972 | 12560797 | 2 | 20140916 | 0 | ||
| 125607972 | 12560797 | 3 | 20141009 | 0 | ||
| 125607972 | 12560797 | 4 | 20140613 | 0 | ||
| 125607972 | 12560797 | 5 | 20140613 | 0 |